Report of the joint ECDC and WHO review of the national tuberculosis programme in Bulgaria
This report outlines the results of the joint ECDC and WHO review of the Bulgarian National Tuberculosis Control Programme.
Tuberculosis in Europe: from passive control to active elimination – high- and low-incidence countries
This four-page evidence brief provides an overview of tuberculosis control and elimination efforts in the EU/EEA, with a particular focus on the epidemiological differences between high- and low-incidence countries.
Week of Annual Meetings of European Tuberculosis Networks
The Week of Annual Meetings of European Tuberculosis Network was a joint effort of ECDC and its international partners to bring together European TB experts to discuss the common goal of eliminating TB in Europe.
Combating HIV and TB through a joint regional action - Northern Dimension Partnership on Public Health and Social Well-being
The aim of this side event was to develop and support effective country and regional responses to further improve the current HIV and tuberculosis situations and reduce their impacts on human lives, economy and society.
Addressing TB and MDR TB in high-priority countries
At this technical meeting, tuberculosis experts from high-incidence countries (Bulgaria, Estonia, Latvia, Lithuania and Romania) discussed ways in which ECDC can support with development and implementation of country strategies to prevent and control the disease.
1st Eastern Partnership Ministerial Conference on Tuberculosis and Multi-Drug Resistance Tuberculosis
High-level meeting to discuss the burden of TB and MDR TB and its elimination as a public health problem in the EU/EEA and Eastern Partnership countries.
Meeting of the Joint ECDC/WHO Surveillance Network for Tuberculosis and Wolfheze Workshops
The 2015 meeting of the Joint ECDC/WHO Surveillance Network for Tuberculosis was held in The Hague, the Netherlands, on 26-27 May 2015. The meeting was organised jointly by the European Centre for Disease Prevention and Control (ECDC) and WHO/Europe for TB surveillance experts from WHO European region including European Union/European Economic Area (EU/EEA) Member States (MSs). The participants included 47 nominated contact points for TB surveillance from 42 countries, as well as experts from ECDC and WHO/Europe, WHO headquarters and country offices. In addition, experts from seven EU Enlargement Countries and from the KNCV TB Foundation (the Netherlands) attended the meeting as observers.
Joint meeting EU/EEA Tuberculosis (TB) Surveillance Network and WHO/Europe National TB Programme Managers
This meeting brought together TB experts from countries belonging to the WHO European Region and surveillance experts from EU/EEA countries to discuss the common goals of eliminating TB in Europe.
The use of Interferon-γ release assays for Tuberculosis Screening in International TravelersArchived
IGRAs are increasingly being considered for the diagnosis of LTBI, as a replacement to the TST, including travel medicine. As with the TST, many uncertainties remain with regard to the efficacy of the IGRAs. It is therefore essential to secure an accurate understanding of these assays‘ known efficacy, so that they be optimally used and only in context with proven effect.